Investor
RA Capital Management
Named in 12 funding announcements in 2026: led 2 and joined 10, across 12 companies. Every round below links to the announcement that named them.
For investors, banks and advisers
Want this delivered, filtered to your mandate?
Every morning: the rounds in your sectors, stages and regions. The investor index as an export. First access to what verified founders say their companies need next, on the founder's terms. Tell us what you are looking for and a person replies with what is available for your desk.
Where it invests
Sectors named in these rounds
Invests alongside
Named on the same announcements
Counted from the announcements only. Appearing on the same round is a fact about the round, not a statement about a relationship.
Rounds led
Where the announcement named RA Capital Management as lead
| Company | Raised | Round | Announced | Co-led with | Source |
|---|---|---|---|---|---|
| Solstice Oncology USA | $225M | Series A | 2026-09-09 | announcement | |
| Typewriter Therapeutics USA | $56M | Series A | 2026-09-02 | co-led with Venture Partners | announcement |
Rounds joined
Where RA Capital Management participated
| Company | Raised | Round | Announced | Led by | Source |
|---|---|---|---|---|---|
| Circle Pharma USA | $92M | Series E | 2026-09-16 | led by Column Group | announcement |
| Superluminal Medicines USA | $60M | Series B | 2026-09-03 | led by BVF Partners | announcement |
| Reframe Systems USA | $40M | Undisclosed | 2026-09-01 | led by Energy Impact Partners | announcement |
| AusperBio USA | $120M | Series C | 2026-08-28 | lead not stated | announcement |
| Abcuro USA | $66M | Series D | 2026-08-18 | led by New Leaf Venture Partners | announcement |
| Infinimmune USA | $75M | Series A | 2026-08-12 | led by Regeneron Ventures, Playground Global | announcement |
| LifeMine Therapeutics USA | $263M | Series E | 2026-08-07 | led by Milky Way Investments | announcement |
| Ollin Biosciences USA | $330M | Series B | 2026-06-24 | led by TCGX, ARCH Venture Partners | announcement |
| Windward Bio Switzerland | $165M | Undisclosed | 2026-05-05 | led by OrbiMed | announcement |
| Adcendo Denmark | $75M | Series C | 2026-04-14 | led by Jeito Capital | announcement |
Investor names are read from the funding announcements and grouped by spelling. A round names its investors the way the publisher did; a firm not named in an announcement does not appear here. Corrections: info@afterraise.com.